| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $851K | +12.5% |
| Cost of Revenue | $1.3M | — |
| R&D Expense | $12.5M | -39.3% |
| SG&A Expense | $8.1M | -10.2% |
| Operating Income | -$26.7M | +35.6% |
| Net Income | -$26.3M | +36.6% |
| EPS (Basic) | -$0.34 | +46.9% |
| EPS (Diluted) | -$0.34 | +46.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.3M | -46.4% |
| Accounts Receivable | $143K | -49.5% |
| Inventory | $106K | — |
| Current Assets | $27.4M | -45.5% |
| Total Assets | $29.8M | -42.1% |
| Current Liabilities | $3.8M | -11.6% |
| Total Liabilities | $5.1M | +16.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.6M | +17.7% |
| Capital Expenditures | $165K | -54.9% |
| Investing Cash Flow | -$165K | +54.9% |
| Financing Cash Flow | $1.0M | -96.3% |
| Free Cash Flow | -$23.8M | +18.2% |
| Stockholders' Equity |
| $24.6M |
| -47.5% |